FibroGen, Inc.
Overview
FibroGen, Inc. is a leading biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat chronic and debilitating conditions. The company's areas of expertise include anemia, fibrosis, and cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to FibroGen, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Lassen Therapeutics, Inc.
United States
3D Imaging Drug Design and Development LLC
United States
3t Biosciences
United States
454 Life Sciences Corporation
United States
A&B Pharmaceuticals
United States
Abbvie Inc.
United States
ABC Biopharmaceuticals, Inc.
United States
ABC Cancer Research Institute
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.